Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Terumo Blood and Cell Technologies and Immunicom Establish Agreement to Launch Breakthrough Cancer Immunotherapy Treatment in Europe
Terumo Blood and Cell Technologies, a medical technology company specializing in a portfolio of products, […]
Thousands Spared Strokes Thanks to New NHS Drug Agreements
More than 20,000 strokes and 5,000 deaths could be averted after NHS England struck new […]
New Clot Busting Drug Could Improve Stroke Treatment
A new clot busting drug developed by scientists at the University of Manchester is able […]
Moderna Announces EU and EEA Countries to Donate More than 70 Million Doses of Moderna COVID-19 Vaccine to Help End COVID-19 Pandemic in Low Income Countries
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced […]
Two Billion Doses of AstraZeneca’s COVID-19 Vaccine Supplied to Countries Across the World Less Than 12 Months After First Approval
AstraZeneca and its partners have released for supply two billion doses of their COVID-19 vaccine […]
Government to Invest £375 Million in Neurodegenerative Disease Research
People living with neurodegenerative diseases could live longer, healthier lives due to innovative new research, […]
ABIONYX Announces New Positive Clinical Results for CER-001 in Kidney Disease Associated with LCAT Deficiency Published in The Journal of Internal Medicine
ABIONYX Pharma (FR0012616852 – ABNX – PEA PME eligible), a new generation biotech company dedicated to […]
Abbott's New Leadless Pacemaker System Meets Primary Endpoints in Pivotal Trial
Abbott (NYSE: ABT) today announced new, late-breaking data from the global Leadless II IDE study evaluating […]
Zipline, Pfizer and BioNTech Collaboration Paves the Way for Automated, On-Demand Delivery of First mRNA COVID-19 Vaccines in Ghana
Zipline, the global leader in instant logistics, Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced […]
MyLife Technologies Raises US$4.0 Million to Further Develop its Vaccine Delivery Technology Through Painless Ceramic Vaccine Patches for 'Pandemic Preparedness'
MyLife Technologies, a Dutch vaccine and drug delivery company, focusing on the development of ceramic […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more